
Novel CK2-Specific Pt(II) Compound, Reversing Cisplatin-Induced Resistance by Inhibiting Cancer клетка Stemness and Suppressing DNA Damage Repair in Non-small клетка Lung Cancer Treatments
Novel CK2-Specific Pt(II) Compound, Reversing Cisplatin-Induced Resistance by Inhibiting Cancer Cell Stemness and Suppressing DNA Damage Repair in Non-small Cell Lung Cancer Treatments
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.